Pralatrexate

Pralatrexate is a pteridine that is the N-4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl derivative of L-glutamic acid. Used for treatment of Peripheral T-Cell Lymphoma, an aggressive form of non-Hodgkins lymphoma. It is grouped under the following drug class(es): Antineoplastic agents and Cytotoxics. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Folotyn, N-{4-[1-(2 and 4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid. Its PubChem CID is 148121.

CAS No 146464-95-1
Molecular Formula C23H23N7O5
Molecular Weight 477.5 g/mol
Synonyms (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid

Frequently Asked Questions